Moderna Inc (MRNA)

NASDAQ HEALTHCARE

$63.96 +3.50% RSI 64 Neutral Add Alert

Moving Averages

SMA 200

$38.42

Price above

Company Profile

Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$19.70B

P/E Ratio

None

EPS

$-8.14

Beta

1.03